Outcome | Control group (n = 36) | CI group (n = 71) | PIB group (n = 73) | F/χ2 value | P | Post-hoc analysis | |
---|---|---|---|---|---|---|---|
Perioperative cumulative opioid consumption (expressed as IV MEQ) (mg, mean ± SD) | 468.91 ± 79.84 | 339.68 ± 56.07 | 305.30 ± 51.35 | 37.348 | < 0.001 | PIB vs. control group: p < 0.001 | |
CI vs. control group: p < 0.001 | |||||||
PIB vs. CI group: p = 0.028 | |||||||
Duration of first-time usage of PCIA (min, median [IQR]) | 35.52 ± 17.24 | 260.81 ± 63.89 | 312.80 ± 83.72 | 96.111 | < 0.001 | PIB vs. control group: p < 0.001 | |
CI vs. control group: p < 0.001 | |||||||
PIB vs. CI group: p = 0.015 | |||||||
Number of PCIA press (median [IQR]) | 10 (8, 12) | 4 (3, 5) | 3 (2, 4) | 26.40 | < 0.001 | PIB vs. control group: p < 0.001 | |
CI vs. control group: p < 0.001 | |||||||
PIB vs. CI group: p = 0.031 | |||||||
QoR-15 scores | At baseline | 143.02 ± 5.73 | 142.90 ± 5.25 | 143.20 ± 6.21 | 0.007 | 0.993 | PIB vs. control group: p = 0.969 |
CI vs. control group: p = 0.934 | |||||||
PIB vs. CI group: p = 0.908 | |||||||
At postoperative 48 h | 73.30 ± 9.64 | 87.60 ± 13.28 | 91.80 ± 12.55 | 6.614 | 0.005 | PIB vs. control group: p = 0.002 | |
CI vs. control group: p = 0.012 | |||||||
PIB vs. CI group: p = 0.438 |